XML 26 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Financial Instruments
12 Months Ended
Dec. 31, 2018
Investments Debt And Equity Securities [Abstract]  
Financial Instruments

5. Financial Instruments

Cash equivalents and short-term and long-term investments, all of which are classified as available-for-sale securities, consisted of the following (in thousands):

 

 

 

December 31, 2018

 

 

December 31, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Estimated

 

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

Amortized

 

 

Unrealized

 

 

Unrealized

 

 

Fair

 

 

 

Cost

 

 

Gain

 

 

(Loss)

 

 

Value

 

 

Cost

 

 

Gain

 

 

(Loss)

 

 

Value

 

Money market funds

 

$

19,500

 

 

$

 

 

$

 

 

$

19,500

 

 

$

31,836

 

 

$

 

 

$

 

 

$

31,836

 

Corporate notes and commercial paper

 

 

166,363

 

 

 

1

 

 

 

(205

)

 

 

166,159

 

 

 

313,307

 

 

 

2

 

 

 

(145

)

 

 

313,164

 

U.S. Treasury bills and government agency securities

 

 

110,270

 

 

 

1

 

 

 

(81

)

 

 

110,190

 

 

 

170,724

 

 

 

 

 

 

(266

)

 

 

170,458

 

 

 

$

296,133

 

 

$

2

 

 

$

(286

)

 

$

295,849

 

 

$

515,867

 

 

$

2

 

 

$

(411

)

 

$

515,458

 

Classified as:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents

 

 

 

 

 

 

 

 

 

 

 

 

 

$

117,836

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

162,793

 

Short-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

178,013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

281,589

 

Long-term investments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

71,076

 

Total cash equivalents and investments

 

 

 

 

 

 

 

 

 

 

 

 

 

$

295,849

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

515,458

 

 

At December 31, 2018, the remaining contractual maturities of available-for-sale securities were less than one year. There have been no significant realized losses on available-for-sale securities for the periods presented. We do not intend to sell the investments with unrealized losses at December 31, 2018, and it is not more likely than not that we will be required to sell those investments with unrealized losses before recovery of their amortized cost bases, which may be maturity. Available-for-sale debt securities that were in a continuous loss position but were not deemed to be other than temporarily impaired were immaterial at both December 31, 2018 and 2017.